Givosiran

Givlaari 189 MG/ML Solucion Inyectable

200 mg/ml solución inyectableSpainMarketedAuthorised 28 Apr 2020

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

GivlaariEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Givosiran

Givlaari 189 MG/ML Solucion Inyectable

200 mg/ml solución inyectableSpainMarketedAuthorised 28 Apr 2020

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

GivlaariEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Givlaari Solution for InjectionTaiwan · 注射液劑 · 艾拉倫股份有限公司

GivlaariUnited States · 189MG BASE/ML · solution · Alnylam Pharms INC

Packs

Pack	Code	Status
GIVLAARI 189 MG/ML SOLUCION INYECTABLE, 1 vial de 1 ml	728211

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Givosiran
Strength: 200 mg/ml
Dosage form: solución inyectable
Route: vía subcutánea
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 28 Apr 2020
Registration: 1201428001
Marketing authorisation holder: Alnylam Netherlands B.V.
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/20/1428